| UniProt ID | GWL_HUMAN | |
|---|---|---|
| UniProt AC | Q96GX5 | |
| Protein Name | Serine/threonine-protein kinase greatwall | |
| Gene Name | MASTL | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 879 | |
| Subcellular Localization | Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Nucleus . Cleavage furrow . During interphase is mainly nuclear, upon nuclear envelope breakdown localizes at the cytoplasm and during mitosis at the centrosomes. Upon mitotic exit | |
| Protein Description | Serine/threonine kinase that plays a key role in M phase by acting as a regulator of mitosis entry and maintenance. Acts by promoting the inactivation of protein phosphatase 2A (PP2A) during M phase: does not directly inhibit PP2A but acts by mediating phosphorylation and subsequent activation of ARPP19 and ENSA at 'Ser-62' and 'Ser-67', respectively. ARPP19 and ENSA are phosphatase inhibitors that specifically inhibit the PPP2R2D (PR55-delta) subunit of PP2A. Inactivation of PP2A during M phase is essential to keep cyclin-B1-CDK1 activity high. Following DNA damage, it is also involved in checkpoint recovery by being inhibited. Phosphorylates histone protein in vitro; however such activity is unsure in vivo. May be involved in megakaryocyte differentiation.. | |
| Protein Sequence | MDPTAGSKKEPGGGAATEEGVNRIAVPKPPSIEEFSIVKPISRGAFGKVYLGQKGGKLYAVKVVKKADMINKNMTHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRDINMMDILTTPSMAKPRQDYSRTPGQVLSLISSLGFNTPIAEKNQDPANILSACLSETSQLSQGLVCPMSVDQKDTTPYSSKLLKSCLETVASNPGMPVKCLTSNLLQSRKRLATSSASSQSHTFISSVESECHSSPKWEKDCQESDEALGPTMMSWNAVEKLCAKSANAIETKGFNKKDLELALSPIHNSSALPTTGRSCVNLAKKCFSGEVSWEAVELDVNNINMDTDTSQLGFHQSNQWAVDSGGISEEHLGKRSLKRNFELVDSSPCKKIIQNKKTCVEYKHNEMTNCYTNQNTGLTVEVQDLKLSVHKSQQNDCANKENIVNSFTDKQQTPEKLPIPMIAKNLMCELDEDCEKNSKRDYLSSSFLCSDDDRASKNISMNSDSSFPGISIMESPLESQPLDSDRSIKESSFEESNIEDPLIVTPDCQEKTSPKGVENPAVQESNQKMLGPPLEVLKTLASKRNAVAFRSFNSHINASNNSEPSRMNMTSLDAMDISCAYSGSYPMAITPTQKRRSCMPHQQTPNQIKSGTPYRTPKSVRRGVAPVDDGRILGTPDYLAPELLLGRAHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILKRDIPWPEGEEKLSDNAQSAVEILLTIDDTKRAGMKELKRHPLFSDVDWENLQHQTMPFIPQPDDETDTSYFEARNTAQHLTVSGFSL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MDPTAGSK -------CCCCCCCC | 14.55 | 22814378 | |
| 8 | Acetylation | MDPTAGSKKEPGGGA CCCCCCCCCCCCCCC | 61.30 | 26051181 | |
| 8 | Ubiquitination | MDPTAGSKKEPGGGA CCCCCCCCCCCCCCC | 61.30 | - | |
| 9 | Acetylation | DPTAGSKKEPGGGAA CCCCCCCCCCCCCCC | 71.49 | 26051181 | |
| 9 | Ubiquitination | DPTAGSKKEPGGGAA CCCCCCCCCCCCCCC | 71.49 | - | |
| 17 | Phosphorylation | EPGGGAATEEGVNRI CCCCCCCCCCCCCCC | 33.75 | 22210691 | |
| 18 | Ubiquitination | PGGGAATEEGVNRIA CCCCCCCCCCCCCCC | 48.29 | 32015554 | |
| 28 | Ubiquitination | VNRIAVPKPPSIEEF CCCCCCCCCCCCHHC | 64.06 | 29967540 | |
| 31 | Phosphorylation | IAVPKPPSIEEFSIV CCCCCCCCCHHCEEE | 51.68 | - | |
| 39 | Ubiquitination | IEEFSIVKPISRGAF CHHCEEEEEECCCCC | 34.66 | 23000965 | |
| 39 (in isoform 1) | Ubiquitination | - | 34.66 | 21890473 | |
| 39 (in isoform 2) | Ubiquitination | - | 34.66 | 21890473 | |
| 39 (in isoform 3) | Ubiquitination | - | 34.66 | 21890473 | |
| 48 | Ubiquitination | ISRGAFGKVYLGQKG ECCCCCCEEEECCCC | 22.66 | 29967540 | |
| 54 | Ubiquitination | GKVYLGQKGGKLYAV CEEEECCCCCEEEEE | 68.76 | 29967540 | |
| 57 | Acetylation | YLGQKGGKLYAVKVV EECCCCCEEEEEEEE | 47.17 | 25953088 | |
| 57 | Ubiquitination | YLGQKGGKLYAVKVV EECCCCCEEEEEEEE | 47.17 | 29967540 | |
| 62 | Ubiquitination | GGKLYAVKVVKKADM CCEEEEEEEEEHHHH | 32.89 | 22817900 | |
| 65 | Ubiquitination | LYAVKVVKKADMINK EEEEEEEEHHHHCCC | 45.27 | 22817900 | |
| 66 | Ubiquitination | YAVKVVKKADMINKN EEEEEEEHHHHCCCC | 37.70 | 22817900 | |
| 66 (in isoform 1) | Ubiquitination | - | 37.70 | 21890473 | |
| 66 (in isoform 2) | Ubiquitination | - | 37.70 | 21890473 | |
| 66 (in isoform 3) | Ubiquitination | - | 37.70 | 21890473 | |
| 72 | Ubiquitination | KKADMINKNMTHQVQ EHHHHCCCCCHHHHH | 36.85 | 29967540 | |
| 75 | Phosphorylation | DMINKNMTHQVQAER HHCCCCCHHHHHHHH | 20.67 | - | |
| 108 | Ubiquitination | QSANNVYLVMEYLIG CCCCCEEEEEEHHHC | 2.29 | 32015554 | |
| 109 | Ubiquitination | SANNVYLVMEYLIGG CCCCEEEEEEHHHCC | 1.18 | 22817900 | |
| 130 | Ubiquitination | HIYGYFDEEMAVKYI HHHCCCCHHHHHHHH | 39.51 | 21963094 | |
| 150 | Ubiquitination | ALDYLHRHGIIHRDL HHHHHHHCCCCCCCC | 22.51 | 22817900 | |
| 158 | Ubiquitination | GIIHRDLKPDNMLIS CCCCCCCCCCCEEEC | 55.40 | 22817900 | |
| 158 (in isoform 1) | Ubiquitination | - | 55.40 | 21890473 | |
| 158 (in isoform 2) | Ubiquitination | - | 55.40 | 21890473 | |
| 158 (in isoform 3) | Ubiquitination | - | 55.40 | 21890473 | |
| 173 | Phosphorylation | NEGHIKLTDFGLSKV CCCCEEECCCCCCEE | 25.04 | 22210691 | |
| 178 | Phosphorylation | KLTDFGLSKVTLNRD EECCCCCCEEEECCC | 26.01 | 22210691 | |
| 179 | Ubiquitination | LTDFGLSKVTLNRDI ECCCCCCEEEECCCC | 44.26 | 21906983 | |
| 179 (in isoform 1) | Ubiquitination | - | 44.26 | 21890473 | |
| 179 (in isoform 2) | Ubiquitination | - | 44.26 | 21890473 | |
| 179 (in isoform 3) | Ubiquitination | - | 44.26 | 21890473 | |
| 181 | Phosphorylation | DFGLSKVTLNRDINM CCCCCEEEECCCCCC | 23.27 | 24260401 | |
| 189 | Ubiquitination | LNRDINMMDILTTPS ECCCCCCHHHHCCCC | 2.21 | 32015554 | |
| 193 | Phosphorylation | INMMDILTTPSMAKP CCCHHHHCCCCCCCC | 36.67 | 20068231 | |
| 194 | Phosphorylation | NMMDILTTPSMAKPR CCHHHHCCCCCCCCC | 15.21 | 21712546 | |
| 196 | Phosphorylation | MDILTTPSMAKPRQD HHHHCCCCCCCCCCC | 29.31 | 28122231 | |
| 199 | Ubiquitination | LTTPSMAKPRQDYSR HCCCCCCCCCCCCCC | 31.90 | 22817900 | |
| 199 (in isoform 1) | Ubiquitination | - | 31.90 | 21890473 | |
| 199 (in isoform 2) | Ubiquitination | - | 31.90 | 21890473 | |
| 199 (in isoform 3) | Ubiquitination | - | 31.90 | 21890473 | |
| 204 | Phosphorylation | MAKPRQDYSRTPGQV CCCCCCCCCCCHHHH | 7.54 | 22199227 | |
| 205 | Phosphorylation | AKPRQDYSRTPGQVL CCCCCCCCCCHHHHH | 37.66 | 22199227 | |
| 207 | Phosphorylation | PRQDYSRTPGQVLSL CCCCCCCCHHHHHHH | 26.32 | 25159151 | |
| 213 | Phosphorylation | RTPGQVLSLISSLGF CCHHHHHHHHHHCCC | 25.46 | 22199227 | |
| 216 | Phosphorylation | GQVLSLISSLGFNTP HHHHHHHHHCCCCCC | 25.46 | 22199227 | |
| 217 | Phosphorylation | QVLSLISSLGFNTPI HHHHHHHHCCCCCCH | 26.05 | 22199227 | |
| 222 | Phosphorylation | ISSLGFNTPIAEKNQ HHHCCCCCCHHHHCC | 17.51 | 25159151 | |
| 258 | Sumoylation | CPMSVDQKDTTPYSS CCCCCCCCCCCCCCH | 53.21 | - | |
| 260 | Phosphorylation | MSVDQKDTTPYSSKL CCCCCCCCCCCCHHH | 36.38 | 30576142 | |
| 261 | Phosphorylation | SVDQKDTTPYSSKLL CCCCCCCCCCCHHHH | 30.29 | 29396449 | |
| 263 | Phosphorylation | DQKDTTPYSSKLLKS CCCCCCCCCHHHHHH | 24.39 | 28985074 | |
| 264 | Phosphorylation | QKDTTPYSSKLLKSC CCCCCCCCHHHHHHH | 23.38 | 21712546 | |
| 265 | Phosphorylation | KDTTPYSSKLLKSCL CCCCCCCHHHHHHHH | 22.83 | - | |
| 266 | Acetylation | DTTPYSSKLLKSCLE CCCCCCHHHHHHHHH | 52.47 | 25953088 | |
| 266 | Ubiquitination | DTTPYSSKLLKSCLE CCCCCCHHHHHHHHH | 52.47 | 29967540 | |
| 269 | Methylation | PYSSKLLKSCLETVA CCCHHHHHHHHHHHH | 49.94 | 115972827 | |
| 269 | Ubiquitination | PYSSKLLKSCLETVA CCCHHHHHHHHHHHH | 49.94 | 32015554 | |
| 270 | Phosphorylation | YSSKLLKSCLETVAS CCHHHHHHHHHHHHH | 24.73 | 21712546 | |
| 274 | Phosphorylation | LLKSCLETVASNPGM HHHHHHHHHHHCCCC | 14.39 | 29214152 | |
| 277 | Phosphorylation | SCLETVASNPGMPVK HHHHHHHHCCCCCHH | 38.94 | 21815630 | |
| 284 | Ubiquitination | SNPGMPVKCLTSNLL HCCCCCHHHHHHHHH | 20.04 | 29967540 | |
| 288 | Phosphorylation | MPVKCLTSNLLQSRK CCHHHHHHHHHHHHH | 16.72 | 21712546 | |
| 292 | Phosphorylation | CLTSNLLQSRKRLAT HHHHHHHHHHHHHHH | 44.34 | 32645325 | |
| 293 | Phosphorylation | LTSNLLQSRKRLATS HHHHHHHHHHHHHHC | 39.47 | 25159151 | |
| 295 | Ubiquitination | SNLLQSRKRLATSSA HHHHHHHHHHHHCCC | 57.94 | 32015554 | |
| 299 | Phosphorylation | QSRKRLATSSASSQS HHHHHHHHCCCCCCC | 28.01 | 23663014 | |
| 300 | O-linked_Glycosylation | SRKRLATSSASSQSH HHHHHHHCCCCCCCC | 20.49 | 23301498 | |
| 300 | Phosphorylation | SRKRLATSSASSQSH HHHHHHHCCCCCCCC | 20.49 | 23663014 | |
| 301 | Phosphorylation | RKRLATSSASSQSHT HHHHHHCCCCCCCCE | 28.02 | 23663014 | |
| 301 | Ubiquitination | RKRLATSSASSQSHT HHHHHHCCCCCCCCE | 28.02 | 30230243 | |
| 303 | Phosphorylation | RLATSSASSQSHTFI HHHHCCCCCCCCEEH | 30.75 | 23663014 | |
| 304 | Phosphorylation | LATSSASSQSHTFIS HHHCCCCCCCCEEHH | 35.10 | 23663014 | |
| 306 | Phosphorylation | TSSASSQSHTFISSV HCCCCCCCCEEHHHH | 26.83 | 23663014 | |
| 308 | Phosphorylation | SASSQSHTFISSVES CCCCCCCEEHHHHHH | 28.10 | 23663014 | |
| 311 | Phosphorylation | SQSHTFISSVESECH CCCCEEHHHHHHHHH | 24.92 | 30108239 | |
| 312 | Phosphorylation | QSHTFISSVESECHS CCCEEHHHHHHHHHC | 25.70 | 23663014 | |
| 315 | Phosphorylation | TFISSVESECHSSPK EEHHHHHHHHHCCCC | 43.28 | 23663014 | |
| 319 | Phosphorylation | SVESECHSSPKWEKD HHHHHHHCCCCCHHH | 61.05 | 25159151 | |
| 320 | Phosphorylation | VESECHSSPKWEKDC HHHHHHCCCCCHHHH | 13.56 | 25159151 | |
| 322 | Ubiquitination | SECHSSPKWEKDCQE HHHHCCCCCHHHHHH | 70.68 | 29967540 | |
| 330 | Phosphorylation | WEKDCQESDEALGPT CHHHHHHCHHHHCCC | 18.18 | 25159151 | |
| 331 | Ubiquitination | EKDCQESDEALGPTM HHHHHHCHHHHCCCH | 44.42 | 32015554 | |
| 350 | Ubiquitination | AVEKLCAKSANAIET HHHHHHHHHCCCCCC | 49.45 | 32015554 | |
| 355 | Ubiquitination | CAKSANAIETKGFNK HHHHCCCCCCCCCCH | 7.48 | 33845483 | |
| 358 | Ubiquitination | SANAIETKGFNKKDL HCCCCCCCCCCHHHH | 49.03 | 29967540 | |
| 362 | Ubiquitination | IETKGFNKKDLELAL CCCCCCCHHHHHHHC | 45.46 | - | |
| 363 | Ubiquitination | ETKGFNKKDLELALS CCCCCCHHHHHHHCC | 69.52 | 29967540 | |
| 370 | Phosphorylation | KDLELALSPIHNSSA HHHHHHCCCCCCCCC | 19.05 | 29255136 | |
| 375 | Phosphorylation | ALSPIHNSSALPTTG HCCCCCCCCCCCCCC | 11.65 | 30278072 | |
| 376 | Phosphorylation | LSPIHNSSALPTTGR CCCCCCCCCCCCCCC | 38.86 | 25159151 | |
| 380 | Phosphorylation | HNSSALPTTGRSCVN CCCCCCCCCCCHHHH | 42.61 | 28176443 | |
| 381 | Phosphorylation | NSSALPTTGRSCVNL CCCCCCCCCCHHHHH | 28.76 | 25159151 | |
| 381 | Ubiquitination | NSSALPTTGRSCVNL CCCCCCCCCCHHHHH | 28.76 | 32015554 | |
| 384 | Phosphorylation | ALPTTGRSCVNLAKK CCCCCCCHHHHHHHH | 24.62 | 21712546 | |
| 390 | Ubiquitination | RSCVNLAKKCFSGEV CHHHHHHHHHHCCCC | 53.92 | 29967540 | |
| 442 | Phosphorylation | EEHLGKRSLKRNFEL HHHHCHHHHHHCCEE | 41.55 | - | |
| 452 | Phosphorylation | RNFELVDSSPCKKII HCCEECCCCHHHHHH | 28.80 | 30266825 | |
| 453 | Phosphorylation | NFELVDSSPCKKIIQ CCEECCCCHHHHHHC | 29.83 | 19664994 | |
| 456 | Acetylation | LVDSSPCKKIIQNKK ECCCCHHHHHHCCCC | 50.84 | 25953088 | |
| 456 | Ubiquitination | LVDSSPCKKIIQNKK ECCCCHHHHHHCCCC | 50.84 | 32015554 | |
| 457 | Ubiquitination | VDSSPCKKIIQNKKT CCCCHHHHHHCCCCC | 52.32 | - | |
| 462 | Ubiquitination | CKKIIQNKKTCVEYK HHHHHCCCCCEEEEE | 32.84 | 30230243 | |
| 464 | Phosphorylation | KIIQNKKTCVEYKHN HHHCCCCCEEEEECC | 24.32 | 26074081 | |
| 483 | Ubiquitination | CYTNQNTGLTVEVQD CEECCCCCCEEEEEE | 27.22 | 32015554 | |
| 492 | Ubiquitination | TVEVQDLKLSVHKSQ EEEEEEEEEEEEHHH | 47.18 | 32015554 | |
| 497 | Ubiquitination | DLKLSVHKSQQNDCA EEEEEEEHHHCCCCC | 48.05 | 29967540 | |
| 498 | Phosphorylation | LKLSVHKSQQNDCAN EEEEEEHHHCCCCCC | 23.32 | 23312004 | |
| 506 | Ubiquitination | QQNDCANKENIVNSF HCCCCCCCHHHHHHC | 33.34 | 29967540 | |
| 512 | Phosphorylation | NKENIVNSFTDKQQT CCHHHHHHCCCCCCC | 20.73 | 29255136 | |
| 514 | Phosphorylation | ENIVNSFTDKQQTPE HHHHHHCCCCCCCCC | 41.95 | 29255136 | |
| 516 | Ubiquitination | IVNSFTDKQQTPEKL HHHHCCCCCCCCCCC | 41.05 | 32015554 | |
| 519 | Phosphorylation | SFTDKQQTPEKLPIP HCCCCCCCCCCCCCC | 30.81 | 25159151 | |
| 542 | Ubiquitination | ELDEDCEKNSKRDYL HCCHHHHHHCCCHHH | 73.23 | 32015554 | |
| 548 | Phosphorylation | EKNSKRDYLSSSFLC HHHCCCHHHHHHCCC | 16.71 | 18691976 | |
| 550 | Phosphorylation | NSKRDYLSSSFLCSD HCCCHHHHHHCCCCC | 20.08 | 29214152 | |
| 551 | Phosphorylation | SKRDYLSSSFLCSDD CCCHHHHHHCCCCCC | 23.63 | 30576142 | |
| 552 | Phosphorylation | KRDYLSSSFLCSDDD CCHHHHHHCCCCCCC | 20.89 | 25159151 | |
| 556 | Phosphorylation | LSSSFLCSDDDRASK HHHHCCCCCCCHHCC | 46.34 | 25159151 | |
| 566 | Phosphorylation | DRASKNISMNSDSSF CHHCCCCCCCCCCCC | 22.70 | 28674151 | |
| 569 | Phosphorylation | SKNISMNSDSSFPGI CCCCCCCCCCCCCCC | 30.17 | 23532336 | |
| 571 | Phosphorylation | NISMNSDSSFPGISI CCCCCCCCCCCCCEE | 33.43 | 28674151 | |
| 572 | Phosphorylation | ISMNSDSSFPGISIM CCCCCCCCCCCCEEE | 40.21 | 28674151 | |
| 577 | Phosphorylation | DSSFPGISIMESPLE CCCCCCCEEECCCCC | 23.07 | 24719451 | |
| 581 | Phosphorylation | PGISIMESPLESQPL CCCEEECCCCCCCCC | 19.87 | 29523821 | |
| 585 | Phosphorylation | IMESPLESQPLDSDR EECCCCCCCCCCCCC | 44.79 | 29523821 | |
| 590 | Phosphorylation | LESQPLDSDRSIKES CCCCCCCCCCCCCHH | 42.48 | 29523821 | |
| 593 | Phosphorylation | QPLDSDRSIKESSFE CCCCCCCCCCHHHCC | 42.90 | 23186163 | |
| 597 | Phosphorylation | SDRSIKESSFEESNI CCCCCCHHHCCCCCC | 35.01 | 30266825 | |
| 598 | Phosphorylation | DRSIKESSFEESNIE CCCCCHHHCCCCCCC | 37.46 | 30266825 | |
| 602 | Phosphorylation | KESSFEESNIEDPLI CHHHCCCCCCCCCEE | 35.59 | 28464451 | |
| 611 | Phosphorylation | IEDPLIVTPDCQEKT CCCCEEECCCCCCCC | 13.35 | 30266825 | |
| 618 | Phosphorylation | TPDCQEKTSPKGVEN CCCCCCCCCCCCCCC | 49.89 | 30266825 | |
| 619 | Phosphorylation | PDCQEKTSPKGVENP CCCCCCCCCCCCCCH | 35.36 | 30266825 | |
| 621 | Ubiquitination | CQEKTSPKGVENPAV CCCCCCCCCCCCHHH | 75.30 | 29967540 | |
| 631 | Phosphorylation | ENPAVQESNQKMLGP CCHHHHHHHHHHHCC | 27.72 | 25159151 | |
| 634 | Ubiquitination | AVQESNQKMLGPPLE HHHHHHHHHHCCCHH | 40.10 | 29967540 | |
| 644 | Acetylation | GPPLEVLKTLASKRN CCCHHHHHHHHHHCC | 46.82 | 18604563 | |
| 644 | Ubiquitination | GPPLEVLKTLASKRN CCCHHHHHHHHHHCC | 46.82 | 32015554 | |
| 657 | Phosphorylation | RNAVAFRSFNSHINA CCCEEEEHHHHCCCC | 23.48 | 25159151 | |
| 660 | Phosphorylation | VAFRSFNSHINASNN EEEEHHHHCCCCCCC | 24.59 | 20068231 | |
| 665 | Phosphorylation | FNSHINASNNSEPSR HHHCCCCCCCCCCCC | 31.86 | 25159151 | |
| 668 | Phosphorylation | HINASNNSEPSRMNM CCCCCCCCCCCCCCC | 55.95 | 25159151 | |
| 671 | Phosphorylation | ASNNSEPSRMNMTSL CCCCCCCCCCCCCHH | 39.86 | 22199227 | |
| 676 | Phosphorylation | EPSRMNMTSLDAMDI CCCCCCCCHHHHHCH | 22.57 | 28348404 | |
| 677 | Phosphorylation | PSRMNMTSLDAMDIS CCCCCCCHHHHHCHH | 17.30 | 28348404 | |
| 696 | Phosphorylation | GSYPMAITPTQKRRS CCCCCEECCCCCCCC | 15.67 | 24719451 | |
| 703 (in isoform 2) | Phosphorylation | - | 20.85 | - | |
| 703 (in isoform 3) | Phosphorylation | - | 20.85 | - | |
| 709 (in isoform 2) | Phosphorylation | - | 56.76 | 25159151 | |
| 709 (in isoform 3) | Phosphorylation | - | 56.76 | 25159151 | |
| 710 | Phosphorylation | SCMPHQQTPNQIKSG CCCCCCCCCCCCCCC | 20.03 | 25159151 | |
| 714 | Ubiquitination | HQQTPNQIKSGTPYR CCCCCCCCCCCCCCC | 4.95 | 29967540 | |
| 715 | Ubiquitination | QQTPNQIKSGTPYRT CCCCCCCCCCCCCCC | 32.82 | 29967540 | |
| 716 | Phosphorylation | QTPNQIKSGTPYRTP CCCCCCCCCCCCCCC | 49.91 | 21712546 | |
| 717 (in isoform 2) | Phosphorylation | - | 26.21 | 25159151 | |
| 717 (in isoform 3) | Phosphorylation | - | 26.21 | 25159151 | |
| 718 | Phosphorylation | PNQIKSGTPYRTPKS CCCCCCCCCCCCCCH | 25.00 | 25159151 | |
| 720 | Phosphorylation | QIKSGTPYRTPKSVR CCCCCCCCCCCCHHH | 27.27 | 18669648 | |
| 721 (in isoform 2) | Phosphorylation | - | 45.84 | 25159151 | |
| 721 (in isoform 3) | Phosphorylation | - | 45.84 | 25159151 | |
| 722 | Phosphorylation | KSGTPYRTPKSVRRG CCCCCCCCCCHHHCC | 29.26 | 18669648 | |
| 725 | Phosphorylation | TPYRTPKSVRRGVAP CCCCCCCHHHCCCCC | 23.27 | 18669648 | |
| 741 | Phosphorylation | DDGRILGTPDYLAPE CCCCCCCCCCCCCHH | 15.00 | 22199227 | |
| 860 | Phosphorylation | QPDDETDTSYFEARN CCCCCCCCCHHHHCH | 32.52 | - | |
| 868 | Phosphorylation | SYFEARNTAQHLTVS CHHHHCHHCCCEEEE | 23.34 | - | |
| 873 | Phosphorylation | RNTAQHLTVSGFSL- CHHCCCEEEECCCC- | 15.53 | 29396449 | |
| 875 | Phosphorylation | TAQHLTVSGFSL--- HCCCEEEECCCC--- | 28.96 | 25159151 | |
| 878 | Phosphorylation | HLTVSGFSL------ CEEEECCCC------ | 36.37 | 25159151 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 75 | T | Phosphorylation | Kinase | PLK1 | P70032 | PSP |
| 194 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 194 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
| 299 | T | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
| 512 | S | Phosphorylation | Kinase | PLK1 | P70032 | PSP |
| 552 | S | Phosphorylation | Kinase | PLK1 | P70032 | PSP |
| 597 | S | Phosphorylation | Kinase | PLK1 | P70032 | PSP |
| 598 | S | Phosphorylation | Kinase | PLK1 | P70032 | PSP |
| 860 | T | Phosphorylation | Kinase | PLK1 | P70032 | PSP |
| 873 | T | Phosphorylation | Kinase | PLK1 | P70032 | PSP |
| 875 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 875 | S | Phosphorylation | Kinase | PLK1 | P70032 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 741 | T | Phosphorylation |
| 18669648 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GWL_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| IGO1_YEAST | IGO1 | physical | 23861665 | |
| CDK18_HUMAN | CDK18 | physical | 26496610 | |
| AAAT_HUMAN | SLC1A5 | physical | 26496610 | |
| SSFA2_HUMAN | SSFA2 | physical | 26496610 | |
| TAP2_HUMAN | TAP2 | physical | 26496610 | |
| MED26_HUMAN | MED26 | physical | 26496610 | |
| TELO2_HUMAN | TELO2 | physical | 26496610 | |
| UBN1_HUMAN | UBN1 | physical | 26496610 | |
| DERL2_HUMAN | DERL2 | physical | 26496610 | |
| RM02_HUMAN | MRPL2 | physical | 26496610 | |
| E41L5_HUMAN | EPB41L5 | physical | 26496610 | |
| FAKD5_HUMAN | FASTKD5 | physical | 26496610 | |
| CEP85_HUMAN | CEP85 | physical | 26496610 | |
| PKHA8_HUMAN | PLEKHA8 | physical | 26496610 | |
| TM263_HUMAN | TMEM263 | physical | 26496610 | |
| ACBD5_HUMAN | ACBD5 | physical | 26496610 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 188000 | Thrombocytopenia 2 (THC2) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-370 AND SER-452, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-293; SER-370; SER-452;SER-453; SER-552; SER-556; SER-631; TYR-720; THR-722; SER-725;THR-741; SER-875 AND SER-878, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-370; SER-512; SER-552;SER-657; SER-665; SER-668; SER-875 AND SER-878, AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-370, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-631, AND MASSSPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-631, AND MASSSPECTROMETRY. | |